MedTrace Logo

Long Term Follow-Up Study for rAAV-GAD Treated Subjects

NCT01301573 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2012-02-22

No results posted yet for this study

Summary

The purpose of this observational study is the long term follow-up of Parkinson's patients who participated in a clinical trial in which they received AAV-GAD gene transfer into the subthalamic nucleus (STN) region of the brain. Patients will be followed once a year for up to five (5) years. The study will monitor and evaluate the long term effects of AAV-GAD and provide long term safety information.

Conditions

Interventions

BIOLOGICAL

rAAV-GAD

Sponsors & Collaborators

  • Neurologix, Inc.

    lead INDUSTRY

Eligibility

Min Age
30 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01301573 on ClinicalTrials.gov